proarrhythmics

the drug has significant proarrhythmic effects in patients with heart failure.

researchers are studying the proarrhythmic potential of new medications.

proarrhythmic risk must be carefully evaluated before prescribing antiarrhythmics.

the study revealed proarrhythmic properties in several beta-blockers.

clinicians monitor patients for proarrhythmic complications during treatment.

some antiarrhythmic agents exhibit proarrhythmic activity under certain conditions.

the proarrhythmic response was observed in the clinical trial group.

understanding the proarrhythmic mechanism is crucial for drug safety.

proarrhythmic events were documented in the post-marketing surveillance.

the fda requires proarrhythmic risk assessment for all new cardiovascular drugs.

proarrhythmic effects can be life-threatening in susceptible individuals.

the committee discussed the proarrhythmic warnings in the drug label.